Mark Davis

The Federal Court's Back-to-Back Guidance On The Implied Undertaking Rule

Trademarks: 2023 Year In Review

Canadian Patent Law In Review 2023: Notable Cases And Trends For 2024

PMPRB Announces Scoping Paper For The Consultation On New Guidelines And Opens Stakeholder Registration For Policy Roundtables

Patented Medicine Prices Review Board Adopts Amended Interim Guidance On Pricing Of New Medicines

Compelling Discovery From Canadian Witnesses

Enforcing Foreign Judgments In Canada

FCA Confirms The Importance Of Counsel's Role In Maintaining The Independence Of Experts

Changes To List Of Comparator Countries Used To Assess Pricing Of Patented Medicines Affirmed On Appeal